GEODE CAPITAL MANAGEMENT, LLC - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 26 filers reported holding ACHILLES THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$19,644
-3.7%
21,5900.0%0.00%
Q2 2023$20,406
-1.3%
21,5900.0%0.00%
Q1 2023$20,672
+108700.0%
21,5900.0%0.00%
Q4 2022$19
-100.0%
21,5900.0%0.00%
Q3 2022$48,000
-11.1%
21,5900.0%0.00%
Q2 2022$54,000
-14.3%
21,5900.0%0.00%
Q1 2022$63,000
-28.4%
21,590
+22.7%
0.00%
Q4 2021$88,000
-35.8%
17,5910.0%0.00%
Q3 2021$137,00017,5910.00%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$27,939,00039.70%
RA Capital Management 5,014,687$12,637,0000.34%
Artal Group S.A. 2,255,375$5,684,0000.30%
Redmile Group, LLC 1,608,089$4,052,0000.16%
KETTLE HILL CAPITAL MANAGEMENT, LLC 242,978$612,0000.15%
Orbimed Advisors 1,584,845$3,994,0000.07%
Baker Brothers Advisors 2,591,366$6,530,0000.04%
Point72 Asset Management, L.P. 1,776,744$4,477,0000.02%
Woodline Partners LP 233,180$588,0000.01%
AXA S.A. 567,310$1,429,8110.00%
View complete list of ACHILLES THERAPEUTICS PLC shareholders